Johnson & Johnson takes pharma brand crown as Pfizer's value falters: ranking

Johnson & Johnson tops 2020's most valuable pharma company list, despite dropping 11% in brand value over the past year. The giant pharma and consumer health company’s brand is currently worth $10.9 billion, according to Brand Finance’s annual assessment of global pharma names.